Surveillance of Antimicrobial Resistance in the ECOWAS Region: Setting the Scene for Critical Interventions Needed

• Published in: Antibiotics (Basel) Vol. 13; no. 7; p. 627
• Main Authors: Aboushady, Ahmed Taha, Manigart, Olivier, Sow, Abdourahmane, Fuller, Walter, Ouedraogo, Abdoul-Salam, Ebruke, Chinelo, Babin, François-Xavier, Gahimbare, Laetitia, Sombié, Issiaka, Stelling, John
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.07.2024
• Subjects: Analysis; Antibiotics; Antimicrobial agents; Antimicrobial resistance; Bacterial infections; Capacity development; COVID-19; Data analysis; Data management; Decision making; Drug resistance; Drug resistance in microorganisms; ECOWAS; Endorsements; Enrollments; Health aspects; infectious diseases; Information management; International organizations; Laboratories; Methicillin; Morbidity; Pandemics; Public health; Reagents; Self evaluation; Staphylococcus infections; surveillance; Surveillance systems; Surveys; West Africa; Sub-Saharan Africa; Guinea Bissau; West Africa; Africa; ECOWAS; surveillance; antimicrobial resistance; West Africa; infectious diseases
• DOI: 10.3390/antibiotics13070627
• ISSN: 2079-6382

Antimicrobial resistance poses a significant challenge to public health globally, leading to increased morbidity and mortality. AMR surveillance involves the systematic collection, analysis, and interpretation of data on the occurrence and distribution of AMR in humans, animals, and the environment for action. The West African Health Organization, part of the Economic Community of West African States (ECOWAS), is committed to addressing AMR in the region. This paper examines the status of AMR surveillance in ECOWAS countries using available WHO data from the TrACSS survey and GLASS enrollments. The analysis reveals that while progress has been made, significant challenges remain. Twelve of the fifteen ECOWAS countries are enrolled in GLASS, and ten have developed national action plans (NAPs) for AMR. However, there is a need to ensure all countries fully implement their NAPs, continue reporting to GLASS, and use the data for evidence-based actions and decision making. Surveillance systems for AMR and antimicrobial consumption/use vary across countries with some demonstrating limited capacity. All countries, except Cabo Verde, reported having a reference laboratory for AMR testing. Strengthening laboratory capabilities, data management and use, and multisectoral coordination are crucial for effective AMR surveillance and response. Based on the findings and the regional context, it is essential to prioritize capacity building, data utilization, and the adoption of standardized guidelines for AMR surveillance. Collaboration among ECOWAS countries, the WAHO, and international partners is essential to address AMR comprehensively. Ensuring a consistent supply of essential antimicrobial medications and reagents is vital.